A study of combination therapy for hyperphosphatemia with calcium-containing phosphate binders and low-calcium dialysate in hemodialysis patients.

Xu Yaowen,Wang Guanyu,Qian Ying

DOI: https://doi.org/10.3969/j.issn.1005-2194.2006.12.010

2006-01-01

Abstract:Objective Hyperphosphatemia is a universal finding in patients with advanced renal insufficiency.We report a study of combination therapy for hyperphosphatemia with calcium-containing phosphate binders and 1.25 mmol/L calcium dialysate in hemodialysis patients.Methods In Shanghai Ruijing Hospital,30 uremic patients who were hospitalized from 2002 to 2004(male/female 18/12,mean age 51.6±14.9 years)with routine hemodialysis(1.5 mmol/L Ca~ 2+ dialysate)2~3 times per week were enrolled in this study,whose serum phosphate>1.78 mmol/L,intact parothyroid(iPTH)<300 pg·mL~ -1 .All patients had been dialyzed with 1.5 mmol/L Ca~ 2+ dialysate or with 1.25 mmol/L Ca~ 2+ dialysate for 6 months.To low-calcium hemodialysis,if serum Ca~ 2+ was >2.37 mmol/L,calcium dose was 1 000 mg/d;if serum Ca~ 2+ was<2.37 mmol/L,calcium dose was 1 000 mg/d,and another calcium dose was given before HD.Results After routine dialysis(1.5 mmol/L Ca~ 2+ dialysate)for 6 months:the serum Ca~ 2+ level had no change[(2.33±0.29)mmol/L to (2.37±0.23)mmol/L];the serum P level had no change[(2.69±0.35)mmol/L to (2.63±0.52)mmol/L];the iPTH had no change[(131.6±62.9)pg·mL~ -1 to (130.7±84.6)pg·mL~ -1 ,P>0.05].After low-calcium dialysis(1.25 mmol/L Ca~ 2+ dialysate)for 6 months:the serum Ca~ 2+ level had no change[(2.37±0.26)mmol/L to (2.41±0.24)mmol/L];the serum P level had decreased significantly from[(2.60±0.47)mmol/L to (2.29±0.58)mmol/L];the iPTH had increased significantly from[(130.7±84.6)pg·mL~ -1 to (169.2±105.8)pg·mL~ -1 ,P<0.05].After low-calcium dialysis(1.25 mmol/L Ca~ 2+ dialysate)for 6 months:the serum phosphate of 11 patients had decreased significantly,accounting for 36.7%;13 patients had decreased,accounting for 43.3%.Conclusion A regime based on the combination of low-calcium dialysate and calcium-containing phosphate binders is capable of effectively managing hyperphosphatemia in the majority of hyperphosphatemia HD patients(iPTH<300 pg·mL~ -1 ).Low-calcium dialysate stimulates the secretion of parathyroid hormone in maintenance hemodialysis patients.